BIOMAT Database Logo BIOMAT Database Logo

Isolation and characterization of circulating fragments of the insulin-like growth factor binding protein-3. 2002

Bernd Kübler, and Claudia Draeger, and Harald John, and Uwe Andag, and Jens-Gerd Scharf, and Wolf-Georg Forssmann, and Thomas Braulke, and Ludger Ständker
Children's Hospital-Biochemistry, University of Hamburg, Martinistr. 52, D-20246, Hamburg, Germany.

Proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3), the major carrier of IGFs in the circulation, is an essential mechanism to regulate IGF bioavailability. To analyze naturally occurring IGFBP-3 fragments a peptide library established from human hemofiltrate was screened. Three IGFBP-3 fragments were detected with apparent molecular masses of 34, 16, and 11 kDa. Mass spectrometric and sequence analysis identified the 16 and 11 kDa peptides as glycosylated and non-glycosylated N-terminal fragments spanning residues Gly1-Ala98 of IGFBP-3. Both the circulating forms and those secreted from IGFBP-3(1-98) overexpressing cells bound IGF. Additionally, two smaller fragments (IGFBP-3(139-157) and IGFBP-3(139-159)) were identified in the hemofiltrate. The data indicate that proteolysis of circulating IGFBP-3 occurs in the variable domain at residues alanine 98, phenylalanine 138, glutamine 157, and tyrosine 159.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006031 Glycosylation The synthetic chemistry reaction or enzymatic reaction of adding carbohydrate or glycosyl groups. GLYCOSYLTRANSFERASES carry out the enzymatic glycosylation reactions. The spontaneous, non-enzymatic attachment of reducing sugars to free amino groups in proteins, lipids, or nucleic acids is called GLYCATION (see MAILLARD REACTION). Protein Glycosylation,Glycosylation, Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017434 Protein Structure, Tertiary The level of protein structure in which combinations of secondary protein structures (ALPHA HELICES; BETA SHEETS; loop regions, and AMINO ACID MOTIFS) pack together to form folded shapes. Disulfide bridges between cysteines in two different parts of the polypeptide chain along with other interactions between the chains play a role in the formation and stabilization of tertiary structure. Tertiary Protein Structure,Protein Structures, Tertiary,Tertiary Protein Structures
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Bernd Kübler, and Claudia Draeger, and Harald John, and Uwe Andag, and Jens-Gerd Scharf, and Wolf-Georg Forssmann, and Thomas Braulke, and Ludger Ständker
Isolation and characterization of proteolytic fragments of insulin-like growth factor-binding protein-3.
January 1996, Hormone research,
Bernd Kübler, and Claudia Draeger, and Harald John, and Uwe Andag, and Jens-Gerd Scharf, and Wolf-Georg Forssmann, and Thomas Braulke, and Ludger Ständker
Isolation and characterization of circulating 13-kDa C-terminal fragments of human insulin-like growth factor binding protein-5.
December 1998, FEBS letters,
Bernd Kübler, and Claudia Draeger, and Harald John, and Uwe Andag, and Jens-Gerd Scharf, and Wolf-Georg Forssmann, and Thomas Braulke, and Ludger Ständker
Predictors of Circulating Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-Binding Protein-3 in Critical Illness.
December 2015, Critical care medicine,
Bernd Kübler, and Claudia Draeger, and Harald John, and Uwe Andag, and Jens-Gerd Scharf, and Wolf-Georg Forssmann, and Thomas Braulke, and Ludger Ständker
Circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are associated with early carotid atherosclerosis.
March 2005, Arteriosclerosis, thrombosis, and vascular biology,
Bernd Kübler, and Claudia Draeger, and Harald John, and Uwe Andag, and Jens-Gerd Scharf, and Wolf-Georg Forssmann, and Thomas Braulke, and Ludger Ständker
Age, sex, and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3.
March 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Bernd Kübler, and Claudia Draeger, and Harald John, and Uwe Andag, and Jens-Gerd Scharf, and Wolf-Georg Forssmann, and Thomas Braulke, and Ludger Ständker
Somatomedin-1 binding protein-3: insulin-like growth factor-1 binding protein-3, insulin-like growth factor-1 carrier protein.
January 2003, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy,
Bernd Kübler, and Claudia Draeger, and Harald John, and Uwe Andag, and Jens-Gerd Scharf, and Wolf-Georg Forssmann, and Thomas Braulke, and Ludger Ständker
Circulating levels of insulin-like growth factor binding protein 3 (IGFBP-3) and insulin-like growth factor I (IGF-I) in perimenopausal women.
November 1994, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA,
Bernd Kübler, and Claudia Draeger, and Harald John, and Uwe Andag, and Jens-Gerd Scharf, and Wolf-Georg Forssmann, and Thomas Braulke, and Ludger Ständker
Insulin-like growth factor-binding protein 1 and insulin-like growth factor-binding protein 3 in pre-eclampsia.
July 1996, British journal of obstetrics and gynaecology,
Bernd Kübler, and Claudia Draeger, and Harald John, and Uwe Andag, and Jens-Gerd Scharf, and Wolf-Georg Forssmann, and Thomas Braulke, and Ludger Ständker
Circulating insulin-like growth factor binding protein-3 and risk of gastrointestinal malignant tumors.
December 2019, Journal of gastroenterology and hepatology,
Bernd Kübler, and Claudia Draeger, and Harald John, and Uwe Andag, and Jens-Gerd Scharf, and Wolf-Georg Forssmann, and Thomas Braulke, and Ludger Ständker
Cloning and characterization of bovine insulin-like growth factor binding protein-3 (bIGFBP-3).
June 1991, Biochemical and biophysical research communications,
Copied contents to your clipboard!